MARCHTX Trademark

Trademark Overview


On Wednesday, March 1, 2023, a trademark application was filed for MARCHTX with the United States Patent and Trademark Office. The USPTO has given the MARCHTX trademark a serial number of 97818084. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Tuesday, July 30, 2024. This trademark is owned by March Therapeutics, Inc.. The MARCHTX trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease

medical treatment using mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease

biotechnological research in the field of mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering
marchtx

General Information


Serial Number97818084
Word MarkMARCHTX
Filing DateWednesday, March 1, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateTuesday, July 30, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 23, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations for mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease
Goods and Servicesmedical treatment using mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering for the treatment of disease
Goods and Servicesbiotechnological research in the field of mitochondrial and nuclear genome engineering, DNA writing, molecular recording, synthetic gene circuit design, and protein and viral engineering

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, October 31, 2023
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMarch Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Party NameMarch Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Wednesday, September 13, 2023ASSIGNED TO EXAMINER
Saturday, March 4, 2023NEW APPLICATION ENTERED
Tuesday, March 21, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 15, 2023NON-FINAL ACTION WRITTEN
Friday, September 15, 2023NON-FINAL ACTION E-MAILED
Friday, September 15, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, October 31, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 1, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, November 1, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, November 1, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 1, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, December 21, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 3, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 23, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 30, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 30, 2024SOU EXTENSION 1 FILED
Tuesday, July 30, 2024SOU EXTENSION 1 GRANTED
Tuesday, March 19, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT